Mechanisms Linking Sleep-Disordered Breathing and Cardiometabolic Disease Risk
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026-04 · 46 (4)
DOI: 10.1161/atvbaha.125.322874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026-04. Verfasst von Rahul Gomez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine and Physiology (R.G., O.M., A.M.), University of California San Diego, La Jolla. Hauptthemen laut MEDLINE: Sleep Apnea Syndromes, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Sleep-disordered breathing (SDB) is a group of disorders defined by intermittent closure or narrowing of the upper airway, caused either by mechanical obstruction or dysregulation of the respiratory centers in the brainstem. The effects of SDB on cardiovascular and metabolic health and disease have been an area of growing interest. Many studies have shown mechanistic links between physiological changes seen in SDB and important cardiometabolic outcomes. In particular, SDB induces alterations in autonomic function, swings in intrathoracic pressure, systemic inflammation, sleep fragmentation, and oxidative stress, with diverse effectors including alterations in cellular gene expression, for example, through microRNA and hypoxia-inducible factor 1, changes in the gut microbiome, and many others. Ultimately, these mechanistic pathways have implications on vascular and myocardial dysfunction, hypertension, insulin sensitivity, lipid metabolism, and weight gain. Several treatment modalities exist for SDB, and are chosen based on the specific disease process and patient preference/tolerance. These therapies result in an improvement in symptoms related to SDB severity and varying levels of cardiometabolic disease risk mitigation. In this review, we will present some important mechanisms of SDB that increase the risk for cardiometabolic disease, and we will discuss therapies and their intended targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine and Physiology (R.G., O.M., A.M.), University of California San Diego, La Jolla.
- Division of Cardiovascular Medicine (W.S.), University of California San Diego, La Jolla.
- Section of Cardiology (W.S.), Jennifer Moreno Department of Veterans Affairs Medical Center, La Jolla, CA.
- Department of Medicine (M.S., Y.-S.J.O., A.S., B.L.), University of California San Diego, La Jolla.
- Section of Sleep Medicine (O.M.), Jennifer Moreno Department of Veterans Affairs Medical Center, La Jolla, CA.
- Center for Physiological Genomics of Low Oxygen (CPGLO) (A.M.), University of California San Diego, La Jolla.
ORCID-Profile: Rahul Gomez, Wei Sun, Omar Mesarwi, Atul Malhotra
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
Zitieren
APA
Gomez, R., Sun, W., Shyy, M., Ou, Y. J., Sihota, A., Liu, B., Mesarwi, O., & Malhotra, A. (2026). Mechanisms Linking Sleep-Disordered Breathing and Cardiometabolic Disease Risk. Arteriosclerosis, Thrombosis, and Vascular Biology, 46(4). https://doi.org/10.1161/atvbaha.125.322874
Vancouver
Gomez R, Sun W, Shyy M, Ou YJ, Sihota A, Liu B, et al. Mechanisms Linking Sleep-Disordered Breathing and Cardiometabolic Disease Risk. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46(4). doi:10.1161/atvbaha.125.322874
BibTeX
@article{Gomez2026,
author = {Gomez, Rahul and Sun, Wei and Shyy, Melody and Ou, Yu-Sin Jennifer and Sihota, Ameeta and Liu, Bryson and Mesarwi, Omar and Malhotra, Atul},
title = {Mechanisms Linking Sleep-Disordered Breathing and Cardiometabolic Disease Risk},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
volume = {46},
number = {4},
doi = {10.1161/atvbaha.125.322874}
}
EUVIMED